Page 6,158«..1020..6,1576,1586,1596,160..6,1706,180..»

Brain Injury, PTSD All Too Common

Posted: Published on November 14th, 2012

The explosive blast that forever changed Vanessa Molinas life struck on a desolate road in Iraq in 2006 as she drove a gun truck guarding a supply convoy. Molina, 30, described the roadside bomb blast as a big, bright orange light that just lasted forever. The force knocked her 2 1/2-ton truck off the road, tore away the drivers-side door and cracked Molinas protective eyewear. The blast was horrible, she recalled. Thats what scares me, the force of that device that much power. A U.S. Army Reserve staff sergeant with the 281st Transportation Company based in Las Cruces, Molina struggles with depression and memory problems that she now recognizes as symptoms of traumatic brain injury and post-traumatic stress disorder. Molina is one of 2,461 veterans of the Iraq and Afghanistan wars treated for PTSD at the New Mexico VA Health Care System between Oct. 1, 2001, and June 30, 2012, according to a report issued last month by the Department of Veterans Affairs. The report found that nearly 30 percent of the 834,463 veterans of the Iraq and Afghanistan wars treated at VA hospitals and clinics nationwide have been diagnosed with PTSD. Immediately after the bomb attack, a commander asked … Continue reading

Posted in Brain Injury Treatment | Comments Off on Brain Injury, PTSD All Too Common

Should hyperbaric oxygen therapy be used to treat combat-related mild traumatic brain injury?

Posted: Published on November 14th, 2012

ScienceDaily (Nov. 13, 2012) The average incidence of traumatic brain injury (TBI) among service members deployed in Middle East conflict zones has increased 117% in recent years, mainly due to proximity to explosive blasts. Therapeutic exposure to a high oxygen environment was hoped to minimize the concussion symptoms resulting from mild TBI, but hyperbaric oxygen (HBO2) treatment may not offer significant advantages, according to an article in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Neurotrauma website at http://www.liebertpub.com/neu. A prospective trial conducted at the U.S. Air Force School of Aerospace Medicine evaluated the benefits of HBO2 therapy on post-concussion symptoms in 50 military servicepersons who had suffered at least one combat-related mild TBI. The study, "The Effect of Hyperbaric Oxygen on Symptoms Following Mild Traumatic Brain Injury," compared the results following 30 sessions of either HBO2 (2.4 atmospheres absolute pressure) or sham treatment over an 8-week period. George Wolf, MD and Leonardo Profenna, MD, U.S. Air Force School of Aerospace Medicine (San Antonio, TX), David Cifu, MD and William Carne, PhD, Virginia Commonwealth University (Richmond), and Laura Baugh, MD, Uniformed Services University of the Health Sciences … Continue reading

Posted in Brain Injury Treatment | Comments Off on Should hyperbaric oxygen therapy be used to treat combat-related mild traumatic brain injury?

First Effective Treatment For Traumatic Brain Injury Reported by Institute of Neurological Recovery, Even Years After …

Posted: Published on November 14th, 2012

LOS ANGELES, Nov. 14, 2012 /PRNewswire/ -- The first treatment breakthrough of its kind for survivors of traumatic brain injury (TBI) or stroke will be published in the December 1 issue of the journal CNS Drugs[1], with an accompanying editorial[2]. To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/first-effective-treatment-for-traumatic-brain-injury-reported-by-institute-of-neurological-recovery-even-years-after-injury-179121491.html The ground-breaking study provides clinical evidence that, for the first time, chronic neurological dysfunction from stroke or traumatic brain injury can rapidly improve following a single dose of a drug that targets brain inflammation, even years after the initial event. There are 5 million people living in the U.S. after TBI and 4.5 million living in the U.S. after stroke, and this is the first treatment of its kind ever available for TBI or stroke survivors after hospital discharge. The observational study[1] of 629 patients, conducted over the course of nearly two years, documents a diverse range of positive effects, including statistically significant rapid clinical improvement in motor impairment, spasticity, cognition, etc. in the stroke group, with a similar pattern of improvement seen in the traumatic brain injury (TBI) group. The study involved 617 patients treated an average of 42 months after stroke and 12 patients treated an … Continue reading

Posted in Brain Injury Treatment | Comments Off on First Effective Treatment For Traumatic Brain Injury Reported by Institute of Neurological Recovery, Even Years After …

Multiple Sclerosis Center offers stateof the-art, full continuum services

Posted: Published on November 14th, 2012

I n the United States, there are 400,000 people living with multiple sclerosis (MS), with nearly one person being diagnosed each hour. New treatments are being introduced, yet the condition is an ongoing health concern. Dan Messina, Ph.D., FACHE, National MS Society board member and senior vice president and COO of CentraState Healthcare System, explains,Receiving a diagnosis can be devastating to an individual and their family, but receiving care that is specialized to the patients unique needs, can help with learning to live with MS. It begins with an accurate diagnosis, establishing an individualized treatment plan and helping patients and families to receive necessary support services. That is why in 2002, CentraState committed to developing the nationally recognized state-of-the-art Linda E. Cardinale MS Center, one of only two in the state. This 4,400-square-foot facility allows patients to receive all primary and support health care services to help them manage their MS.Through our center, patients can meet with our 11 certified MS specialists in physical therapy, occupational therapy and speech language pathology, the most of any MS Center in the nation.We also offer integrated, holistic care with neurologists, urologists, physiatrists, nutritionists, psychotherapists and social workers, as well as support groups and … Continue reading

Posted in MS Treatment | Comments Off on Multiple Sclerosis Center offers stateof the-art, full continuum services

Opexa Therapeutics to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

Posted: Published on November 14th, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)-- Opexa Therapeutics, Inc. (OPXA), a company developing Tcelna, a novel T-cell therapy for multiple sclerosis (MS), today announced that Neil K. Warma, President and Chief Executive Officer, will present at the Lazard Capital Markets 9th Annual Healthcare Conference on Wednesday, November 14, 2012, at 9:00 a.m. EST. The conference will be held at The Pierre Hotel in New York City. A live and archived webcast of the company presentation can be accessed via the Investor Relations section of the Companys website at http://www.opexatherapeutics.com. About Tcelna Tcelna is a personalized therapy that is specifically tailored to each patient's disease profile. Tcelna is manufactured using ImmPath, Opexa's proprietary method for the production of a patient-specific T-cell immunotherapy, which encompasses the collection of blood from the MS patient, isolation of peripheral blood mononuclear cells, generation of an autologous pool of myelin-reactive T-cells (MRTCs) raised against selected peptides from myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG) and proteolipid protein (PLP), and the return of these expanded, irradiated T-cells back to the patient. These attenuated T-cells are reintroduced into the patient via subcutaneous injection to trigger a therapeutic immune system response. Opexa believes the potential combination of efficacy, superior safety, … Continue reading

Posted in MS Treatment | Comments Off on Opexa Therapeutics to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

MS Dhoni hails 'strong character' Yuvraj Singh after winning his battle with cancer

Posted: Published on November 14th, 2012

MS Dhoni today paid tribute to Yuvraj Singh as the Indian prepares to return to Test cricket after winning his battle with cancer. The 30-year-old has not played Test cricket for a year after treatment for a rare form of lung cancer. He made a successful international return in the World T20 before scoring a double century in the Duleep Trophy followed by five wickets and a 50 for India A against England. Dhoni said today: He looks in good shape. It takes a lot of fitness to score a double hundred. Im just hoping he does not have to field for two days. There is no need for the car which is capable of a long haul to be driven the full distance. Dhoni said Yuvrajs recovery is an indication of his character. Hes aggressive, said the skipper. Hes someone who really wants to perform at the top level. The best thing for us is he bats at five or six and is a left-arm spinnner. Its a very important role for us because we dont have a genuine all-rounder and play with four bowlers. His contribution will be very important. He can be quite intimidating the way he … Continue reading

Posted in MS Treatment | Comments Off on MS Dhoni hails 'strong character' Yuvraj Singh after winning his battle with cancer

ViroPharma's Cinryze® (C1 Esterase Inhibitor [Human]) Prophylaxis Study Showed Safety Data of Escalating Doses in …

Posted: Published on November 14th, 2012

EXTON, Pa., Nov. 13, 2012 /PRNewswire/ -- ViroPharma Incorporated (VPHM) today announced important data from an open-label, multicenter study to assess the safety, tolerability, and treatment effect of escalating doses of C1 INH-nf in patients with HAE who were not adequately controlled with 1000 U every 3 or 4 days. The results of this study were presented at the 2012 annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Anaheim, California. The data provide evidence for the safety profile of Cinryze (C1 esterase inhibitor [human]) at doses up to 2500 units in patients with hereditary angioedema (HAE). HAE is a rare, severely debilitating, life-threatening genetic disorder caused by a deficiency of a human plasma protein called C1 inhibitor. The presentation titled, Safety and Efficacy of Escalating Doses of C1 Esterase Inhibitor [Human] (Cinryze) as Prophylaxis in Patients with Hereditary Angioedema (HAE) was presented by Dr. Jonathan A. Bernstein from the University of Cincinnati. The study was a post marketing FDA requirement to assess the safety and tolerability of escalating doses of Cinryze, with specific interest in thrombogenicity and immunogenicity. This study enrolled 20 eligible subjects over a 3 year period. Subjects with qualifying HAE attack rates, … Continue reading

Comments Off on ViroPharma's Cinryze® (C1 Esterase Inhibitor [Human]) Prophylaxis Study Showed Safety Data of Escalating Doses in …

Testosterone Levels Before

Posted: Published on November 14th, 2012

Testosterone Levels Before After 7 Months of Therapy Please SHARE THIS VIDEO if you found it useful or if you know somebody who is suffering and scared. Thank you. MY STORY My name is Noah and on May 18 2011, I had a rare reaction to a vaccine called VIVITROL and consequently spiraled into a major, agitated, suicidal depression with depersonalization. I lost 25 lbs in 4 weeks and was in full panic or near panic for 8 weeks straight mixed with the darkest most painful depression I cold have ever imagined. I immediately could not work and had to move in with my parents who along with many siblings and friends had to watch me 24/7 as I was so suicidal. I was eventually hospitalized. Getting through each day seemed truly unbearable and I knew I would surely die. I have been put on many many different SSRI's SNRI's Tricyclics, Mood stabilizers, anti psychotics, holistic meds, acupuncture and even a form of shock therapy called RTMS. I barely saw any improvement in my condition for a full year. It was decided I had treatment resistant depression and I spent nearly every moment in tears. As a last … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Testosterone Levels Before

Osteoporosis risk factors after the menopause

Posted: Published on November 14th, 2012

ScienceDaily (Nov. 13, 2012) A preliminary study of 127 post-menopausal women on hormone replacement therapy in Portugal suggests that there are several risk factors associated with osteoporosis and bone fracture these include age, low bone mineral density, a sedentary lifestyle, coffee consumption and ovariectomy. Details are reported later this month in the International Journal of Medical Engineering and Informatics. Osteoporosis is a disease of the skeleton commonly associated with low bone mass and is predominant in elderly, post-menopausal women. Elza Fonseca of the Polytechnic Institute of Bragana and colleagues there and at the Medical Imaging Centre in Porto, point out that osteoporosis was common in the group of Portuguese women studied. They discuss data from different geographic regions concerning this public health problem. The team hoped to identify common factors and so underpin knowledge on this potentially debilitating and critical bone disease. The clinical relevance is that those with the condition are highly susceptible to bone fractures, which can lead to pain, hospitalisation and disablement, particularly in the case of hip, spine and wrist fracture. Indeed, fractures linked to osteoporosis are unfortunately often linked to patient death. Bone mass density as determined by dual energy X-ray absorptiometry (DEXA) has been … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Osteoporosis risk factors after the menopause

The truth behind hormone replacement therapy

Posted: Published on November 14th, 2012

JACKSONVILLE, Fla. -- The ads are enticing. Real people, even local personalities, sharing their hormone replacement success stories. "I feel like a whole new person." - Hormone Replacement Therapy Testimonial "It's made such a difference in my life." - Jenn Jackson, Hormone Replacement Therapy Testimonial "And now I feel better than ever. You don't have to suffer with hormone issues." - Toni Foxx-WQIK "So I'm listening to the ads ... You're desperate at times. You know? You are desperate to feel better, to lose the weight. You're desperate and I guess that's where I was," said one patient who did not want to reveal her identity. Tired and unhappy about her body post-menopause, this Jacksonville patient turned to HRC Medical in March of this year, but two treatments and hundreds of dollars later, she says the results were not as advertised. "By the second injection I got depressed, hair growth," she explained. "he hair growth was just tremendous. I was going through puberty again." This patient is not alone. According to the Better Business Bureau, consumers have filed dozens of complaints against HRC Medical. Just last month, Tennessee's Attorney General filed a complaint against the company for "endangering the health … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on The truth behind hormone replacement therapy

Page 6,158«..1020..6,1576,1586,1596,160..6,1706,180..»